‘Oxford-AstraZeneca’ will not be made for under 30s in England

Oxford-AstraZenecaBritain made a new decision regarding the vaccine while the debates about it continued. Pharmaceuticals and Healthcare Products Regulatory Authority (MHRAIn the statement, it was stated that the Oxford-AstraZeneca vaccine still has great benefits in preventing serious diseases. In the statement, which was announced that 79 blood clotting cases were reported until 31 March and 19 of these people died, it was emphasized that it was not determined what caused the blood clotting. It was…

"‘Oxford-AstraZeneca’ will not be made for under 30s in England"